文献速递系统性红斑狼疮

可溶性尿激活白细胞黏附分子是狼疮肾炎的强预测指标

Soluble urine activated leukocyte cell adhesion molecule is a strong predictor of lupus nephritis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

研究纳入122例经活检证实的狼疮肾炎患者,在多个研究地点前瞻性收集1年内第0、12、26、52周的血和尿样本,检测可溶性ALCAM与CD6水平。基线横断面分析显示尿ALCAM与尿蛋白肌酐比值、肾脏SLEDAI及医师总体评估显著相关,与血清C3、C4负相关,预测狼疮肾炎的AUC为0.97,而尿CD6的AUC为0.71。3个月内尿ALCAM的变化可区分第52周的无应答者与应答者。

要点

  • 基线尿ALCAM与尿蛋白肌酐比值、肾脏SLEDAI及医师总体评估显著相关,与血清C3、C4负相关。
  • 尿ALCAM预测狼疮肾炎的AUC为0.97,尿CD6的AUC为0.71。
  • 3个月内尿ALCAM的变化可区分第52周的无应答者与应答者。

核心结论

  • 尿ALCAM反映狼疮肾炎的变化,可能预测应答状态。

研究设计与样本

  • 前瞻性研究,纳入经活检证实的狼疮肾炎患者122例,在多个研究地点于1年内第0、12、26、52周收集血清和尿样本,检测可溶性ALCAM与CD6水平,并用同一样本的尿肌酐标准化尿ALCAM和尿CD6水平。

主要发现

  • 基线横断面分析显示尿ALCAM与尿蛋白肌酐比值、肾脏SLEDAI及医师总体评估显著相关,与血清C3和C4负相关。
  • 受试者工作特征曲线分析显示尿ALCAM预测狼疮肾炎的AUC为0.97,尿CD6的AUC为0.71。
  • 3个月内尿ALCAM的变化可区分第52周的无应答者与应答者。

关键数值与推荐

  • 尿ALCAM预测狼疮肾炎的AUC为0.97,尿CD6的AUC为0.71。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate urinary activated leucocyte cell adhesion molecule (ALCAM) and CD6 as predictors of LN progression or disease resolution across a 1-year study. METHODS: Serum and urine samples from biopsy proven LN subjects (n = 122) were prospectively collected over the course of a year at 3- or 6-month intervals (weeks 0, 12, 26 and 52) across multiple study sites and assessed for soluble ALCAM and CD6 levels. Urine creatinine from the same urine sample was used to normalize the levels of urinary ALCAM and urinary CD6. Measured levels of serum and urine ALCAM and CD6 were then analysed against disease metrics cross-sectionally and longitudinally. RESULTS: Cross-sectional analysis at baseline revealed that urinary ALCAM significantly correlated with urine protein creatinine ratio, renal SLEDAI, and the Physician Global Assessment (PGA), and negatively correlated with serum C3 and C4. Receiver operating characteristic curve analysis demonstrated that urinary ALCAM is a predictor of LN with an area under the curve (AUC) of 0.97, compared with urinary CD6 with an AUC of 0.71. Importantly, the change in urinary ALCAM over a 3-month period distinguished between non-responders and responders at week 52. CONCLUSION: Urinary ALCAM is reflective of changes in LN and may be predictive of response status.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chu D, Schwartz N, Ampudia J, et al. Soluble urine activated leukocyte cell adhesion molecule is a strong predictor of lupus nephritis. Rheumatology (Oxford). 2025. PMID: 39404817. doi:10.1093/rheumatology/keae559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。